Develops drugs for cancer and leukemia treatments.
Jun 2026Revenue $77.2M/yrExpenses $395M/yr
No trendCash runway ≈ 4.4 years from Jun 2026
Figures by year
When will Kura Oncology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $77.2M and expenses $395M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $67.5M | $371M | −$304M |
| Dec 2024 | $53.9M | $247M | −$193M |
| Dec 2023 | $0.00 | $166M | −$166M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.